Selected article for: "absence presence and International license"

Author: Xuesen Zhao; Shuangli Zheng; Danying Chen; Mei Zheng; Xinglin Li; Guoli Li; Hanxin Lin; Jinhong Chang; Hui Zeng; Ju-Tao Guo
Title: LY6E Restricts the Entry of Human Coronaviruses, including the currently pandemic SARS-CoV-2
  • Document date: 2020_4_5
  • ID: dxuabscn_12
    Snippet: In summary, while it is very interesting to know that LY6E is capable of modulating the 303 entry of many RNA viruses, we only begin to uncover the mechanism of this fascinating host 304 factor and define its pathobiological role in virus infection (41, 63) . Further understanding the 305 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the .....
    Document: In summary, while it is very interesting to know that LY6E is capable of modulating the 303 entry of many RNA viruses, we only begin to uncover the mechanism of this fascinating host 304 factor and define its pathobiological role in virus infection (41, 63) . Further understanding the 305 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.02.021469 doi: bioRxiv preprint role and mechanism of LY6E in viral infections will establish a scientific basis for development 306 of therapeutics to harness its function for the treatment of viral diseases. The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.02.021469 doi: bioRxiv preprint ACGCTGGTGCCCTACGGAAACG-3´; GAPDH, 5´-GAAGGTGAAGGTCGGAGTCAAC-3 398 ´ and 5´-CAGAGTTAAAAGCAGCCCTGGT-3´. Gene expression was calculated using the 2 -△ 399 △ CT method, normalized to GAPDH as described previously (31, 40) . presence of tet over that in the absence of tet. The error bars refer to standard deviations (n=4). 793 **, p <0.001, compared to mock treatment. 794 . CC-BY-NC-ND 4.0 International license author/funder. It is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.04.02.021469 doi: bioRxiv preprint

    Search related documents:
    Co phrase search for related documents
    • CT method and gene expression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • CT method and RNA virus: 1, 2, 3, 4
    • CT method and standard deviation: 1, 2, 3, 4
    • CT method and viral disease: 1, 2, 3, 4, 5, 6
    • error bar and standard deviation: 1, 2, 3, 4, 5, 6, 7
    • gene expression and mock treatment: 1, 2, 3, 4, 5, 6
    • gene expression and RNA virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • gene expression and scientific basis: 1, 2, 3
    • gene expression and standard deviation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • gene expression and tet presence: 1
    • gene expression and viral disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • gene expression and viral disease treatment: 1
    • mock treatment and RNA virus: 1, 2
    • mock treatment and viral disease: 1
    • previously describe and RNA virus: 1, 2
    • previously describe and viral disease: 1, 2
    • previously describe and viral disease treatment: 1, 2
    • RNA virus and viral disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • RNA virus and viral disease treatment: 1, 2, 3